Pulmonary Drug Delivery Market: Increasing Incidence of Respiratory Diseases
Increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis. Global respiratory drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 …